London · Delayed Price · Currency is GBP · Price in GBX PureTech Health Company Description
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody.
The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions.
In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage.
PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.
| Country | United Kingdom |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 90 |
| CEO | Robert Lyne |
Contact Details
Address: 6 Tide Street Boston, Massachusetts 02210 United States | |
| Phone | 617 482 2333 |
| Website | puretechhealth.com |
Stock Details
| Ticker Symbol | PRTC |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | GB00BY2Z0H74 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Robert Lyne J.D., L.L.B. | Chief Executive Officer and Director |
| Dr. Robert S. Langer Jr., Ph.D., ScD | Co-Founder and Non-Executive Director |
| Dr. Eric Elenko Ph.D. | Co-Founder and President |
| Dr. David R. Elmaleh Ph.D. | Co-Founder and Senior Advisor |
| Lauren A. White M.B.A. | Chief Financial Officer |
| Charles Sherwood III, J.D., Ph.D. | Chief Operating Officer, General Counsel and Company Secretary |
| Michael Inbar CPA, M.B.A. | Chief Accounting Officer |
| Allison Mead Talbot | Senior Vice President of Communications and Head of Investor Relations |
| Spencer Ball | Executive Vice President of Human Resources |
| Aleksandra Filipovic M.D., Ph.D. | Head of Oncology |